#USA #New York #Gross Law Firm #ZTS #Zoetis Inc

Zoetis Inc. Class Action Lawsuit Information

On July 14, 2026, The Gross Law Firm announced an important update for shareholders of Zoetis Inc. (NYSE: ZTS). The law firm is reaching out to individuals who purchased Zoetis shares during a specified class period, from January 14, 2025, to May 6, 2026. This announcement comes as the firm prepares to represent investors in a class action lawsuit aimed at addressing significant grievances and alleged misconduct by the company.

Allegations Against Zoetis Inc.

The lawsuit alleges that during the specified class period, Zoetis Inc. and its executives made materially false or misleading statements regarding the company’s financial performance and product growth, especially with their key veterinary products. Shareholders are being informed of the following key allegations:

1. Decline in Veterinarian Prescription Growth: There were reports indicating that the growth and adoption rates of Zoetis' prescription medication, Librela—specifically designed for canine pain relief—were slowing down. This change was significantly tied to increased caution among clinicians following safety warnings by the FDA concerning serious neurological complications associated with the medication in dogs.

2. Market Share Loss of Simparica Trio: Zoetis was also alleged to be losing significant market share for its Simparica Trio product. This loss occurred as it faced competition from a cheaper alternative that offered broader usage indications in a declining market for veterinary medications.

3. Competitive Challenges in Dermatology Products: Furthermore, Zoetis' well-known dermatology products, Apoquel and Cytopoint, were reportedly losing market traction to recently launched competing therapies, which also contributed to a dip in sales and overall market confidence in the brand’s product line.

Important Dates and Actions for Shareholders

Shareholders are urged to act promptly as the deadline to seek lead plaintiff status is July 27, 2026. This status is optional for participation in any recovery but may yield certain advantages in the class action process. To facilitate your involvement:

• - Register Your Information: Investors who have purchased shares during the designated time frame should register on the Gross Law Firm's website to ensure they are included in the ongoing case updates and potentially receive recovery benefits.

• - Participate Without Cost: Participation in this case is free of charge, and there will be no financial obligation required from shareholders to join the lawsuit.

Why Choose The Gross Law Firm?

The Gross Law Firm has established a reputation as a nationally recognized litigant in class action cases. They focus on protecting the rights of investors who have been misled or suffered losses due to fraudulent actions by companies. Their commitment is to hold businesses accountable for ethical conduct and reaffirm good corporate citizenship while fighting for the best interest of affected shareholders.

Conclusion

The importance of this class action lawsuit cannot be overstated for Zoetis shareholders who might have faced losses due to alleged deceptive practices. By acting quickly to register, shareholders can ensure they have a voice in this significant legal action. For those who are affected, The Gross Law Firm stands ready to advocate for justice and financial recovery.

For more information, individuals can reach out to The Gross Law Firm at [email protected] or by calling (646) 453-8903. They are located at 15 West 38th Street, 12th floor, New York, NY 10018.